Results 201 to 210 of about 72,847 (303)
Perspectives in biomedicine: Superfoods and antioxidant power classification
Abstract The market value of natural food antioxidants will double to 8 billion USD by 2033, driven by a global consumer demand for ‘clean label’ products and proactive wellness solutions. However, the industrial application and health labelling (commercial brands) of these compounds remain severely constrained by inconsistent analytical methods.
Domenico Fuoco, Gregory S. Patience
wiley +1 more source
Diphenylpyraline Derivatives Are Allosteric Agonists of the CB<sub>1</sub> Cannabinoid Receptor. [PDF]
Eldeeb K +8 more
europepmc +1 more source
Insomnia affects around one in ten adults. In this 2‐year UK Medical Cannabis Registry cohort study of 211 adults with insomnia, treatment with cannabis‐based medicinal products was associated with a sustained improvement in self‐reported sleep quality across 24 months.
Aran Koye +7 more
wiley +1 more source
Synthetic Cannabinoids: Metabolism, Biomarkers of Exposure and Advanced Analytical Strategies in Forensic and Clinical Toxicology. [PDF]
Gomes TM +3 more
europepmc +1 more source
Hemp seed counting and morphometric analysis method comparison
Abstract The USDA ARS Hemp Germplasm Laboratory recently acquired over 800 hemp accessions (Cannabis sativa L.). Variation in hemp seed size characteristics is needed to develop quantitative standards to support the transition of hemp grain into a commodity.
Tyler Gordon, Zachary Stansell
wiley +1 more source
Neurotoxicity of Synthetic Cannabinoid Receptor Agonist Cumyl-PINACA: An In Vitro Study on Rat Cortical Neurons and Astrocytes. [PDF]
Jurič DM +4 more
europepmc +1 more source
ABSTRACT Background Kush, a synthetic drug combining cannabinoids and nitazene opioids, has emerged as a major public health concern in Sierra Leone, with reported prevalence and clinical severity increasing markedly as it was first identified.
Alvin Turay +5 more
wiley +1 more source

